Charcot-Marie-Tooth Disease and Implications on Corneal Refractive Surgery.
Philip C HoopesAlyson N TukanNour BundogjiYasmyne C RonquilloPublished in: Ophthalmology and therapy (2022)
Charcot-Marie-Tooth (CMT) disease is the most common inherited polyneuropathy, with a characteristic phenotype of distal muscle weakness, atrophy, and sensory loss. Variable ocular involvement has been documented in patients with CMT, with optic atrophy as the most frequently reported symptom. Although the Charcot-Marie-Tooth Association has generally deemed laser-assisted in situ keratomileuses (LASIK) a safe option for patients with CMT, reports of corneal refractive surgery are lacking in this patient population. This commentary discusses the current understanding of CMT, including its ocular manifestations, and additional specific testing to consider when evaluating these patients for corneal refractive surgery.
Keyphrases
- minimally invasive
- cataract surgery
- coronary artery bypass
- optical coherence tomography
- end stage renal disease
- surgical site infection
- ejection fraction
- newly diagnosed
- chronic kidney disease
- wound healing
- optic nerve
- prognostic factors
- case report
- patient reported outcomes
- peritoneal dialysis
- patient reported
- atrial fibrillation
- high resolution
- high speed
- adverse drug
- electronic health record